top of page

Addressing Repetitive Vascular Access Challenges in Chronic Kidney Disease:

Access for Life presents a potential solution to the well-documented clinical challenge of maintaining long-term patency and functionality of central venous access for hemodialysis in patients with chronic kidney disease (CKD). Our initial target market addresses this unmet clinical need.

Our device is a novel, subcutaneously implanted access technology incorporating sensor enhancements. This design aims to:

  • Mitigate peripheral vein integrity through atraumatic cannulation, potentially reducing the incidence of central vein stenosis and thrombosis, common complications in hemodialysis patients.

  • Reduce iatrogenic complications associated with repetitive percutaneous cannulation by enabling self-cannulation. This could improve patient autonomy and potentially promote the adoption of home hemodialysis, a modality demonstrably associated with improved patient outcomes.

  • Facilitate real-time data collection during hemodialysis, potentially enabling hemodynamic monitoring and the optimization of dialysis treatment parameters.

In essence, the Access for Life device is designed to:

  1. Improve long-term central venous access patency and functionality.

  2. Reduce access-related complications through atraumatic cannulation and potential facilitation of home hemodialysis.

  3. Offer potential for improved hemodialysis treatment optimization through real-time data collection.

JEM Mount Sinai  2021-09-02.png


Needle out, valve down, entry point to vein closed

bottom of page